1. Home
  2. LIVE vs SCYX Comparison

LIVE vs SCYX Comparison

Compare LIVE & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIVE
  • SCYX
  • Stock Information
  • Founded
  • LIVE 1968
  • SCYX 1999
  • Country
  • LIVE United States
  • SCYX United States
  • Employees
  • LIVE N/A
  • SCYX N/A
  • Industry
  • LIVE Other Specialty Stores
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LIVE Consumer Discretionary
  • SCYX Health Care
  • Exchange
  • LIVE Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • LIVE 26.6M
  • SCYX 28.5M
  • IPO Year
  • LIVE N/A
  • SCYX 2014
  • Fundamental
  • Price
  • LIVE $13.41
  • SCYX $0.72
  • Analyst Decision
  • LIVE
  • SCYX
  • Analyst Count
  • LIVE 0
  • SCYX 0
  • Target Price
  • LIVE N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • LIVE 208.6K
  • SCYX 200.7K
  • Earning Date
  • LIVE 08-07-2025
  • SCYX 08-07-2025
  • Dividend Yield
  • LIVE N/A
  • SCYX N/A
  • EPS Growth
  • LIVE N/A
  • SCYX N/A
  • EPS
  • LIVE N/A
  • SCYX N/A
  • Revenue
  • LIVE $455,142,000.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • LIVE N/A
  • SCYX $410.22
  • Revenue Next Year
  • LIVE N/A
  • SCYX $248.83
  • P/E Ratio
  • LIVE N/A
  • SCYX N/A
  • Revenue Growth
  • LIVE 5.53
  • SCYX N/A
  • 52 Week Low
  • LIVE $6.25
  • SCYX $0.66
  • 52 Week High
  • LIVE $25.88
  • SCYX $2.28
  • Technical
  • Relative Strength Index (RSI)
  • LIVE 45.91
  • SCYX 46.77
  • Support Level
  • LIVE $13.44
  • SCYX $0.67
  • Resistance Level
  • LIVE $15.70
  • SCYX $0.83
  • Average True Range (ATR)
  • LIVE 1.89
  • SCYX 0.05
  • MACD
  • LIVE -0.18
  • SCYX 0.01
  • Stochastic Oscillator
  • LIVE 13.11
  • SCYX 46.35

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: